Pacific Islander, Māori, and African American populations demonstrate both elevated baseline hyperuricemia and greater obesity-attributable gout risk compared to white populations, likely reflecting genetic variants in urate transporters (ABCG2, SLC2A9) interacting with metabolic factors [47]. This evidence concerns the gene SLC2A9 and hyperuricemia.